Farxiga (dapagliflozin) is a prescription drug, commonly taken as a 10 mg oral tablet once daily, to lower blood glucose levels in Type 2 diabetes mellitus, reduce the risk of hospitalization and cardiovascular death in congestive heart failure (CHF), and lower the risk of progression of chronic kidney disease (CKD)
Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates
& 12 One of the interesting conditions in clinical pharmacy is Pernicious Anemia
5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain "semaglutide." The defendants named in these lawsuits employ tactics that deceive patients into believing compounded products have been reviewed and approved by FDA or have equivalent safety or effectiveness as Novo Nordisk's approved semaglutide medicines
Conclusion Understanding proper peptide storage and reconstitution techniques is essential for preserving their quality, stability, and structural integrity